The store will not work correctly when cookies are disabled.
1-(2,4-dichloro-5-hydroxybenzyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one
ID: ALA4072166
PubChem CID: 137639597
Max Phase: Preclinical
Molecular Formula: C15H12Cl2N2O2
Molecular Weight: 323.18
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(=O)n(Cc2cc(O)c(Cl)cc2Cl)c2ccccc21
Standard InChI: InChI=1S/C15H12Cl2N2O2/c1-18-12-4-2-3-5-13(12)19(15(18)21)8-9-6-14(20)11(17)7-10(9)16/h2-7,20H,8H2,1H3
Standard InChI Key: KGRKNWWLCTXQOC-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
5.3775 -6.3380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0872 -5.9285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0843 -5.1059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3757 -4.7006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6695 -5.9290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6662 -5.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8886 -4.8633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4113 -5.5258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8939 -6.1844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6446 -6.9626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5941 -5.5292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6330 -4.0871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1773 -3.4776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9752 -3.6473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5194 -3.0386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2639 -2.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4592 -2.0965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9186 -2.7065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8074 -1.6513 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
6.3193 -3.2057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1178 -2.5435 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
9 10 1 0
8 11 2 0
7 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
15 20 1 0
18 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 323.18 | Molecular Weight (Monoisotopic): 322.0276 | AlogP: 3.40 | #Rotatable Bonds: 2 |
Polar Surface Area: 47.16 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.35 | CX Basic pKa: ┄ | CX LogP: 3.86 | CX LogD: 3.54 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.79 | Np Likeness Score: -1.07 |
References
1. Fujimoto J, Okamoto R, Noguchi N, Hara R, Masada S, Kawamoto T, Nagase H, Tamura YO, Imanishi M, Takagahara S, Kubo K, Tohyama K, Iida K, Andou T, Miyahisa I, Matsui J, Hayashi R, Maekawa T, Matsunaga N.. (2017) Discovery of 3,5-Diphenyl-4-methyl-1,3-oxazolidin-2-ones as Novel, Potent, and Orally Available Δ-5 Desaturase (D5D) Inhibitors., 60 (21): [PMID:29023121] [10.1021/acs.jmedchem.7b01210] |